Dennis R. Doose

1.7k total citations
27 papers, 1.3k citations indexed

About

Dennis R. Doose is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Dennis R. Doose has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pediatrics, Perinatology and Child Health, 21 papers in Psychiatry and Mental health and 8 papers in Oncology. Recurrent topics in Dennis R. Doose's work include Epilepsy research and treatment (20 papers), Pharmacological Effects and Toxicity Studies (20 papers) and Drug Transport and Resistance Mechanisms (8 papers). Dennis R. Doose is often cited by papers focused on Epilepsy research and treatment (20 papers), Pharmacological Effects and Toxicity Studies (20 papers) and Drug Transport and Resistance Mechanisms (8 papers). Dennis R. Doose collaborates with scholars based in United States, Israel and United Kingdom. Dennis R. Doose's co-authors include R. K. Nayak, Sally A. Walker, Meir Bialer, William E. Rosenfeld, Stefan Schwabe, Shean‐Sheng Wang, L. G. Gisclon, Anthony J. Streeter, Rǎjesh C. Sachdeo and Richard P. Shank and has published in prestigious journals such as Tetrahedron, Epilepsia and Clinical Pharmacokinetics.

In The Last Decade

Dennis R. Doose

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dennis R. Doose United States 20 937 856 213 184 154 27 1.3k
Cinzia Fattore Italy 17 772 0.8× 731 0.9× 230 1.1× 118 0.6× 117 0.8× 28 1.1k
M. J. Eadie Australia 23 716 0.8× 974 1.1× 126 0.6× 174 0.9× 162 1.1× 88 1.7k
B. Rambeck Germany 21 1.3k 1.4× 1.3k 1.5× 282 1.3× 425 2.3× 219 1.4× 56 1.7k
Willi Cawello Germany 23 612 0.7× 549 0.6× 199 0.9× 226 1.2× 232 1.5× 75 1.4k
J. W. A. Meijer Netherlands 20 1.0k 1.1× 1.0k 1.2× 396 1.9× 180 1.0× 59 0.4× 47 1.7k
R. K. Nayak United States 16 435 0.5× 406 0.5× 112 0.5× 123 0.7× 280 1.8× 26 986
Arne Reimers Norway 19 802 0.9× 842 1.0× 120 0.6× 131 0.7× 97 0.6× 50 1.2k
G. Oteri Italy 16 752 0.8× 657 0.8× 209 1.0× 127 0.7× 93 0.6× 32 1.0k
Neville Ratnaraj United Kingdom 24 868 0.9× 659 0.8× 538 2.5× 190 1.0× 217 1.4× 48 1.3k
Lennart Gram Denmark 21 1.1k 1.2× 963 1.1× 467 2.2× 97 0.5× 57 0.4× 37 1.4k

Countries citing papers authored by Dennis R. Doose

Since Specialization
Citations

This map shows the geographic impact of Dennis R. Doose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis R. Doose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis R. Doose more than expected).

Fields of papers citing papers by Dennis R. Doose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis R. Doose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis R. Doose. The network helps show where Dennis R. Doose may publish in the future.

Co-authorship network of co-authors of Dennis R. Doose

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis R. Doose. A scholar is included among the top collaborators of Dennis R. Doose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis R. Doose. Dennis R. Doose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zannikos, Peter, Dennis R. Doose, G Leitz, et al.. (2011). Pharmacokinetics and Tolerability of Rabeprazole in Children 1 to 11 Years Old With Gastroesophageal Reflux Disease. Journal of Pediatric Gastroenterology and Nutrition. 52(6). 691–701. 16 indexed citations
2.
Chien, Shuchean, Caiping Yao, Tom Verhaeghe, et al.. (2007). An Interaction Study Between the New Antiepileptic and CNS Drug Carisbamate (RWJ‐333369) and Lamotrigine and Valproic Acid. Epilepsia. 48(7). 1328–1338. 19 indexed citations
3.
Yao, Caiping, Dennis R. Doose, Gerald Novak, & Meir Bialer. (2006). Pharmacokinetics of the New Antiepileptic and CNS Drug RWJ‐333369 Following Single and Multiple Dosing to Humans. Epilepsia. 47(11). 1822–1829. 26 indexed citations
4.
Bialer, Meir, Bhavna Solanki, Tom Verhaeghe, et al.. (2006). Pharmacokinetic Interaction Study between the New Antiepileptic and CNS Drug RWJ‐333369 and Carbamazepine in Healthy Adults. Epilepsia. 47(11). 1830–1840. 23 indexed citations
5.
Specchio, Luigi Maria, Malka Britzi, Emilio Perucca, et al.. (2005). A Comparative Study of the Effect of Carbamazepine and Valproic Acid on the Pharmacokinetics and Metabolic Profile of Topiramate at Steady State in Patients with Epilepsy. Epilepsia. 46(7). 1046–1054. 23 indexed citations
6.
Shank, Richard P., Dennis R. Doose, Anthony J. Streeter, & Meir Bialer. (2005). Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase. Epilepsy Research. 63(2-3). 103–112. 88 indexed citations
7.
8.
Doose, Dennis R., Martin J. Brodie, Elaine A. Wilson, et al.. (2003). Topiramate and Lamotrigine Pharmacokinetics during Repetitive Monotherapy and Combination Therapy in Epilepsy Patients. Epilepsia. 44(7). 917–922. 48 indexed citations
9.
Britzi, Malka, Stefan Soback, Nina Isoherranen, et al.. (2003). Analysis of Topiramate and Its Metabolites in Plasma and Urine of Healthy Subjects and Patients With Epilepsy by Use of a Novel Liquid Chromatography–Mass Spectrometry Assay. Therapeutic Drug Monitoring. 25(3). 314–322. 36 indexed citations
10.
Sachdeo, Rǎjesh C., René H. Levy, Anthony J. Streeter, et al.. (2002). Topiramate and Phenytoin Pharmacokinetics During Repetitive Monotherapy and Combination Therapy to Epileptic Patients. Epilepsia. 43(7). 691–696. 50 indexed citations
11.
Berry, David J., Frank Besag, Felicity Jane Pool, Jaya Natarajan, & Dennis R. Doose. (2002). Lack of an Effect of Topiramate on Lamotrigine Serum Concentrations. Epilepsia. 43(8). 818–823. 18 indexed citations
12.
Rosenfeld, William E., Dennis R. Doose, Sally A. Walker, James Baldassarre, & R. Reife. (1999). A study of topiramate pharmacokinetics and tolerability in children with epilepsy. Pediatric Neurology. 20(5). 339–344. 65 indexed citations
13.
Glauser, Tracy A., et al.. (1999). Topiramate Pharmacokinetics in Infants. Epilepsia. 40(6). 788–791. 62 indexed citations
14.
Hecken, Anne Van, Marleen Depré, Jozef Arnout, et al.. (1998). Pharmacodynamics and pharmacokinetics of RWJ-53308, a nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist, in healthy men. Naunyn-Schmiedeberg s Archives of Pharmacology. 358(1). 1 indexed citations
15.
Doose, Dennis R., et al.. (1998). Levofloxacin Does Not Alter Cyclosporine Disposition. The Journal of Clinical Pharmacology. 38(1). 90–93. 21 indexed citations
16.
Rosenfeld, William E., Dennis R. Doose, Sally A. Walker, & R. K. Nayak. (1997). Effect of Topiramate on the Pharmacokinetics of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol in Patients with Epilepsy. Epilepsia. 38(3). 317–323. 159 indexed citations
17.
Doose, Dennis R., Sally A. Walker, L. G. Gisclon, & R. K. Nayak. (1996). Single‐Dose Pharmacokinetics and Effect of Food on the Bioavailability of Topiramate, A Novel Antiepileptic Drug. The Journal of Clinical Pharmacology. 36(10). 884–891. 106 indexed citations
18.
Sachdeo, Rǎjesh C., et al.. (1996). Steady‐State Pharmacokinetics of Topiramate and Carbamazepine in Patients with Epilepsy During Monotherapy and Concomitant Therapy. Epilepsia. 37(8). 774–780. 121 indexed citations
19.
Nayak, R. K., Dennis R. Doose, & N.P.V. Nair. (1987). The Bioavailability and Pharmacokinetics of Oral and Depot Intramuscular Haloperidol in Schizophrenic Patients. The Journal of Clinical Pharmacology. 27(2). 144–150. 43 indexed citations
20.
Doose, Dennis R. & Betty‐Ann Hoener. (1983). Synthesis of the 5‐nitrofuran 2,4‐diacetylamino‐6‐(5‐nitro‐2‐furyl)‐1,3,5‐triazine‐6‐14C. Journal of Labelled Compounds and Radiopharmaceuticals. 20(4). 495–500. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cinzia Fattore Breakdown of academic impact, for papers by M. J. Eadie Breakdown of academic impact, for papers by B. Rambeck Breakdown of academic impact, for papers by Willi Cawello Breakdown of academic impact, for papers by J. W. A. Meijer Breakdown of academic impact, for papers by R. K. Nayak Breakdown of academic impact, for papers by Arne Reimers Breakdown of academic impact, for papers by G. Oteri Breakdown of academic impact, for papers by Neville Ratnaraj Breakdown of academic impact, for papers by Lennart Gram
Rankless by CCL
2026